RLS Global AB has signed an agreement with Region Stockholm and Gotland for ChloraSolv®
RLS Global AB is pleased to inform that ChloraSolv is awarded on the current tender agreement in Region Stockholm and Gotland. The agreement is effective August 15[th], 2020. The clinical evaluation has been very positive and ChloraSolv is now available to all healthcare providers in the region such as inpatient- and outpatient care, primary care, and private care providers. The agreement is the largest in Sweden in wound care.“Now we see another result of the intensive work that RLS has completed in the autumn 2019 and spring 2020 to gain access to the different regions in Sweden, says